The New England Journal of Medicine

Original Article

Deletion of IKZF1 and Prognosis in Acute Lymphoblastic Leukemia

Charles G. Mullighan, M.D., Xiaoping Su, Ph.D., Jinghui Zhang, Ph.D., Ina Radtke, Ph.D., Letha A.A. Phillips, B.S., Christopher B. Miller, B.S., Jing Ma, Ph.D., Wei Liu, Ph.D., Cheng Cheng, Ph.D., Brenda A. Schulman, Ph.D., Richard C. Harvey, Ph.D., I-Ming Chen, D.V.M., Robert J. Clifford, Ph.D., William L. Carroll, M.D., Gregory Reaman, M.D., W. Paul Bowman, M.D., Meenakshi Devidas, Ph.D., Daniela S. Gerhard, Ph.D., Wenjian Yang, Ph.D., Mary V. Relling, Pharm.D., Sheila A. Shurtleff, Ph.D., Dario Campana, M.D., Michael J. Borowitz, M.D., Ph.D., Ching-Hon Pui, M.D., Malcolm Smith, M.D., Ph.D., Stephen P. Hunger, M.D., Cheryl L. Willman, M.D., James R. Downing, M.D., and the Children's Oncology Group

N Engl J Med 2009; 360:470-480January 29, 2009